FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

31995511000001107: Promazine 50mg tablets (Ennogen Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Mar 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
96952201000001118 Promazine 50mg tablets (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
96952301000001110 Promazine 50mg tablets (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Promazine 50mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) Is a Product containing precisely promazine hydrochloride 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) Has active ingredient Promazine hydrochloride false Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) Has specific active ingredient Promazine hydrochloride true Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Promazine 50mg tablets (Ennogen Healthcare Ltd) 100 tablet Has AMP True Promazine 50mg tablets (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start